Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.9% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
1
users have commented on this narrative
39
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
CarParts.com
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Aging Vehicles And Digital Channels Will Expand Future Markets
Key Takeaways Expansion into new segments, digital adoption, and strategic investments in technology are expected to drive revenue growth and improve operational efficiency. Focus on direct sales channels, private labels, and diversified fee-based income is enhancing customer loyalty, gross margin, and recurring revenue streams.
View narrative
US$1.35
FV
n/a
intrinsic discount
1.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
Updated
narrative
Alector
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Breakthrough CNS Treatments Will Reshape Neurodegenerative Care
Key Takeaways Success in upcoming clinical trials could position Alector as a commercial leader in treating neurodegenerative diseases, expanding its patient reach and supporting sustained growth. Proprietary technology enables innovation and efficiency in CNS drug development, with regulatory tailwinds and strong partnerships enhancing long-term earnings prospects and de-risking the pipeline.
View narrative
US$4.51
FV
n/a
intrinsic discount
65.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
Updated
narrative
Chambal Fertilisers and Chemicals
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Agricultural Diversification Will Boost Prospects But Risk Regulatory Shifts
Key Takeaways Diversification into new agri-input segments and digital initiatives is strengthening Chambal's growth resilience and market positioning. Supportive government policies and capital-efficient strategies enhance margin stability and long-term earnings potential.
View narrative
₹624.00
FV
15.3% undervalued
intrinsic discount
6.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
1 day ago
author updated this narrative
Lynas Rare Earths
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Mt Weld And Malaysia Expansion Will Secure Rare Earth Supply
Key Takeaways Expanded capacity, new partnerships, and integration into non-Chinese supply chains position Lynas for increased output, pricing power, and revenue growth amid rising global demand. Completion of major projects, improved ESG credentials, and shifting geopolitical dynamics support stronger margins, stable cash flow, and enhanced long-term market positioning.
View narrative
AU$9.99
FV
45.1% overvalued
intrinsic discount
46.46%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
59
users have followed this narrative
15 days ago
author updated this narrative
Mersana Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
ADC Trials Will Reshape Personalized Cancer Treatments
Key Takeaways Advancements in targeted oncology therapeutics and strategic partnerships are diversifying income, reducing dilution risk, and strengthening long-term financial stability. Differentiated clinical assets and alignment with personalized medicine trends position the company for accelerated growth, premium pricing, and possible M&A or licensing opportunities.
View narrative
US$28.29
FV
73.8% undervalued
intrinsic discount
-5.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
about 12 hours ago
author updated this narrative
Clearfield
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Expanding Broadband Adoption Will Power Next Generation Networks
Key Takeaways Expanding broadband adoption, fueled by government support and tech trends like AI and 5G, is driving strong demand for Clearfield's solutions and supporting robust growth prospects. Operational efficiencies, innovative products, and diversification into new markets are enhancing recurring revenue, customer retention, and sustained margin improvement.
View narrative
US$49.25
FV
36.0% undervalued
intrinsic discount
11.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
Sweetgreen
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Infinite Kitchen Rollout Will Improve Operational Efficiency And Customer Loyalty
Key Takeaways Automation and optimized store formats are boosting operational efficiency, customer satisfaction, and profitability, with a focus on scaling these models for long-term margin gains. Menu innovation, enhanced digital engagement, and targeted growth in strategic locations are driving higher customer frequency, sales growth, and improved returns on capital.
View narrative
US$14.00
FV
34.6% undervalued
intrinsic discount
14.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
Updated
narrative
EMCOR Group
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Rising Demand In Data Centers And Healthcare Will Expand Markets
Key Takeaways Robust sector demand, sustainability trends, and digital integration are driving a growing, diversified project backlog, supporting revenue growth and improved long-term margins. Strategic acquisitions and investment in talent and prefabrication enhance operational efficiency, vertical market reach, and competitive strength despite labor market challenges.
View narrative
US$681.67
FV
10.5% undervalued
intrinsic discount
9.67%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
29
users have followed this narrative
1 day ago
author updated this narrative
Planisware SAS
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Digital Transformation And SaaS Expansion Will Spark Rebound
Key Takeaways SaaS and cloud growth, along with expansion into regulated sectors, are structurally boosting margins and securing long-term revenue stability through specialized offerings. Delayed contracts due to macro uncertainty are viewed as temporary, with strong demand and digital transformation supporting a likely rebound in revenue growth.
View narrative
€26.07
FV
31.0% undervalued
intrinsic discount
12.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies